Publications

Cost-effectiveness of 13-valent pneumococcal conjugate vaccination in Mongolia.

SUNDARAM, N; Chen, C; Yoong, J; Luvsan, M-E; Fox, K; Sarankhuu, A; La Vincente, S; JIT, M;

2017

Vaccine, (2017).35 7 10.1016/j.vaccine.2016.12.070.

Observational study to estimate the changes in the effectiveness of bacillus Calmette-Guérin (BCG) vaccination with time since vaccination for preventing tuberculosis in the UK.

MANGTANI, P; NGUIPDOP-DJOMO, P; KEOGH, RH; Trinder, L; SMITH, PG; FINE, PE; Sterne, J; Abubakar, I; VYNNYCKY, E; Watson, J; Elliman, D; Lipman, M; RODRIGUES, LC;

2017

HEALTH TECHNOLOGY ASSESSMENT, (2017).21 39 10.3310/hta21390.

Enhancement of cytokine-driven NK cell IFN-γ production after vaccination of HCMV infected Africans.

DARBOE, A; DANSO, E; CLARKE, E; Umesi, A; Touray, E; Wegmuller, R; MOORE, SE; RILEY, EM; Goodier, MR;

2017

European journal of immunology, (2017).47 6 10.1002/eji.201746974.

Supplementary material from "Exploring the role of competition induced by non-vaccine serotypes for herd protection following pneumococcal vaccination".

Masala, G; Lipsitch, M; BOTTOMLEY, C; FLASCHE, S;

2017

, Figshare (2017).

Using Data from Macaques To Predict Gamma Interferon Responses after Mycobacterium bovis BCG Vaccination in Humans: a Proof-of-Concept Study of Immunostimulation/Immunodynamic Modeling Methods.

RHODES, SJ; Sarfas, C; KNIGHT, GM; White, A; Pathan, AA; McShane, H; Evans, TG; FLETCHER, H; Sharpe, S; WHITE, RG;

2017

Clinical and vaccine immunology, (2017).24 3 10.1128/CVI.00525-16.

Estimated economic impact of vaccinations in 73 low- and middle-income countries, 2001-2020.

Ozawa, S; Clark, S; Portnoy, A; Grewal, S; Stack, ML; Sinha, A; Mirelman, A; Franklin, H; Friberg, IK; Tam, Y; Walker, N; CLARK, A; Ferrari, M; Suraratdecha, C; Sweet, S; Goldie, SJ; Garske, T; Li, M; Hansen, PM; Johnson, HL; Walker, D;

2017

Bulletin of the World Health Organization, (2017).95 9 10.2471/BLT.16.178475.

Lower vaccine uptake amongst older individuals living alone: A systematic review and meta-analysis of social determinants of vaccine uptake.

JAIN, A; VAN HOEK, AJ; BOCCIA, D; THOMAS, SL;

2017

Vaccine, (2017).35 18 10.1016/j.vaccine.2017.03.013.

Assay optimisation and technology transfer for multi-site immuno-monitoring in vaccine trials.

SMITH, SG; Harris, SA; Satti, I; Bryan, D; Walker, KB; DOCKRELL, HM; McShane, H; Ho, MM;

2017

PloS one, (2017).12 10 10.1371/journal.pone.0184391.

IMPACT OF PNEUMOCOCCAL CONJUGATE VACCINE ON INVASIVE PNEUMOCOCCAL DISEASE IN THE GAMBIA: POPULATION-BASED SURVEILLANCE OVER 9 YEARS.

Mackenzie, G; Hill, P; JEFFRIES, D; Hossain, I; Ndiaye, M; Badji, H; Ikumapayi, U; Salaudeen, R; Jarju, S; Antonio, M; Ceesay, L; Sowe, D; Jasseh, M; Mulhollan, K; Knoll, M; Levine, O; Howie, S; Adegbola, R; GREENWOOD, B; Corrah, T;

2017

AMERICAN JOURNAL OF TROPICAL MEDICINE AND HYGIENE, (2017).97 5

Pneumococcal conjugate vaccine induced IgG and nasopharyngeal carriage of pneumococci: Hyporesponsiveness and immune correlates of protection for carriage.

OJAL, J; Hammitt, LL; Gaitho, J; SCOTT, JA G; Goldblatt, D;

2017

Vaccine, (2017).35 35 Pt 10.1016/j.vaccine.2017.05.088.